Septerna, Inc.

SEPN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Revenue $26.7M $26.5M $24.1M $21.5M $119.0K $219.0K $212.0K $176.0K
Cost of Revenue — — — — — — — —
Gross Profit — — — — — — — —
Gross Margin — — — — — — — —
Operating Expenses
Research & Development $35.1M $29.5M $31.9M $24.3M $22.2M $19.3M $19.3M $17.8M
SG&A Expense $8.5M $10.3M $8.3M $7.1M $6.9M $6.9M $5.6M $4.9M
Operating Income $-16.8M $-13.3M $-16.0M $2.6M $-29.0M $-25.9M $-24.7M $-22.6M
Operating Margin -62.9% -50.1% -66.4% 12.2% -24,351.3% -11,831.1% -11,659.4% -12,812.5%
Interest Expense — — — — — — — —
Pretax Income $-12.1M $-8.3M $-10.7M $8.2M $-24.8M $-21.5M $-20.8M $-20.7M
Income Tax Expense $973.0K $337.0K $12.0K $0 $0 $0 $-564.0K $-136.0K
Net Income $-13.0M $-8.6M $-10.7M $8.2M $-24.8M $-21.5M $-20.7M $-20.5M
Net Margin -48.7% -32.6% -44.5% 38.0% -20,872.3% -9,806.4% -9,749.1% -11,660.8%
EPS (Basic) $-0.29 $-0.19 $-0.23 $0.05 $-0.56 $-0.49 $14.52 $-2.10
EPS (Diluted) $-0.29 $-0.19 $-0.23 $0.05 $-0.56 $-0.49 $14.52 $-2.10
Shares Outstanding (Basic) 45.0M 44.8M 44.3M 177.4M 44.2M 43.9M 9.9M 9.8M
Shares Outstanding (Diluted) 45.0M 44.8M 44.3M 182.4M 44.2M 43.9M 9.9M 9.8M
Dividends Per Share — — — — — — — —
← Newer Page 1 of 2 Older →